LncAABR07025387.1 Enhances Myocardial Ischemia/Reperfusion Injury Via miR-205/ACSL4-Mediated Ferroptosis

Ferroptosis is associated with the pathology of myocardial ischemia/reperfusion (MI/R) injury following myocardial infarction, which is a leading cause of death worldwide. Although long noncoding RNAs (lncRNAs) are known to regulate gene expression, their roles in MI/R-induced ferroptosis remain unc...

Full description

Bibliographic Details
Main Authors: Weixin Sun, Xiang Wu, Peng Yu, Qian Zhang, Le Shen, Jiandong Chen, Huaqin Tong, Manlu Fan, Haibo Shi, Xiaohu Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-02-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2022.672391/full
_version_ 1798018290128257024
author Weixin Sun
Weixin Sun
Weixin Sun
Weixin Sun
Xiang Wu
Xiang Wu
Xiang Wu
Peng Yu
Peng Yu
Qian Zhang
Qian Zhang
Le Shen
Le Shen
Jiandong Chen
Jiandong Chen
Huaqin Tong
Huaqin Tong
Huaqin Tong
Manlu Fan
Manlu Fan
Manlu Fan
Haibo Shi
Haibo Shi
Haibo Shi
Xiaohu Chen
Xiaohu Chen
author_facet Weixin Sun
Weixin Sun
Weixin Sun
Weixin Sun
Xiang Wu
Xiang Wu
Xiang Wu
Peng Yu
Peng Yu
Qian Zhang
Qian Zhang
Le Shen
Le Shen
Jiandong Chen
Jiandong Chen
Huaqin Tong
Huaqin Tong
Huaqin Tong
Manlu Fan
Manlu Fan
Manlu Fan
Haibo Shi
Haibo Shi
Haibo Shi
Xiaohu Chen
Xiaohu Chen
author_sort Weixin Sun
collection DOAJ
description Ferroptosis is associated with the pathology of myocardial ischemia/reperfusion (MI/R) injury following myocardial infarction, which is a leading cause of death worldwide. Although long noncoding RNAs (lncRNAs) are known to regulate gene expression, their roles in MI/R-induced ferroptosis remain unclear. In this study, we explored the lncRNA expression profiles in a rat model of MI/R injury and found that the novel lncRNA, lncAABR07025387.1, was highly expressed in MI/R-injured myocardial tissues and hypoxia/reoxygenation (H/R)-challenged myocardial cells. Silencing lncAABR07025387.1 improved MI/R injury in vivo and inhibited myocardial cell ferroptosis under H/R conditions. Bioinformatics analyses and luciferase, pull-down, and RNA-binding immunoprecipitation assays further revealed that lncAABR07025387.1 interacted with miR-205, which directly targeted ACSL4, a known contributor to ferroptosis. Furthermore, downregulating miR-205 reversed the ACSL4 inhibition induced by silencing lncAABR07025387.1. These findings suggest that, mechanistically, lncAABR07025387.1 negatively regulates miR-205 expression and subsequently upregulates ACSL4-mediated ferroptosis. In conclusion, this study demonstrates that lncAABR07025387.1 acts as a competing endogenous RNA during MI/R injury and highlights the therapeutic potential of lncRNAs for treating myocardial injury.
first_indexed 2024-04-11T16:21:38Z
format Article
id doaj.art-e3ac23d22f7c4e85848aab00acfd88eb
institution Directory Open Access Journal
issn 2296-634X
language English
last_indexed 2024-04-11T16:21:38Z
publishDate 2022-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cell and Developmental Biology
spelling doaj.art-e3ac23d22f7c4e85848aab00acfd88eb2022-12-22T04:14:21ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2022-02-011010.3389/fcell.2022.672391672391LncAABR07025387.1 Enhances Myocardial Ischemia/Reperfusion Injury Via miR-205/ACSL4-Mediated FerroptosisWeixin Sun0Weixin Sun1Weixin Sun2Weixin Sun3Xiang Wu4Xiang Wu5Xiang Wu6Peng Yu7Peng Yu8Qian Zhang9Qian Zhang10Le Shen11Le Shen12Jiandong Chen13Jiandong Chen14Huaqin Tong15Huaqin Tong16Huaqin Tong17Manlu Fan18Manlu Fan19Manlu Fan20Haibo Shi21Haibo Shi22Haibo Shi23Xiaohu Chen24Xiaohu Chen25Department of Cardiology, Yancheng TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Yancheng, ChinaDepartment of Cardiology, Jiangsu Province Hospital of Chinese Medicine, Nanjing, ChinaDepartment of Cardiology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, ChinaFirst Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, ChinaFirst Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, ChinaDepartment of Gerontology, Jiangsu Province Hospital of Chinese Medicine, Nanjing, ChinaDepartment of Gerontology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, ChinaDepartment of Cardiology, Jiangsu Province Hospital of Chinese Medicine, Nanjing, ChinaDepartment of Cardiology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, ChinaDepartment of Cardiology, Jiangsu Province Hospital of Chinese Medicine, Nanjing, ChinaDepartment of Cardiology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, ChinaDepartment of Cardiology, Jiangsu Province Hospital of Chinese Medicine, Nanjing, ChinaDepartment of Cardiology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, ChinaDepartment of Cardiology, Jiangsu Province Hospital of Chinese Medicine, Nanjing, ChinaDepartment of Cardiology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, ChinaDepartment of Cardiology, Jiangsu Province Hospital of Chinese Medicine, Nanjing, ChinaDepartment of Cardiology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, ChinaFirst Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, ChinaDepartment of Cardiology, Jiangsu Province Hospital of Chinese Medicine, Nanjing, ChinaDepartment of Cardiology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, ChinaFirst Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, ChinaDepartment of Cardiology, Jiangsu Province Hospital of Chinese Medicine, Nanjing, ChinaDepartment of Cardiology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, ChinaDepartment of Cardiology, Liyang City Hospital of TCM, Changzhou, ChinaDepartment of Cardiology, Jiangsu Province Hospital of Chinese Medicine, Nanjing, ChinaDepartment of Cardiology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, ChinaFerroptosis is associated with the pathology of myocardial ischemia/reperfusion (MI/R) injury following myocardial infarction, which is a leading cause of death worldwide. Although long noncoding RNAs (lncRNAs) are known to regulate gene expression, their roles in MI/R-induced ferroptosis remain unclear. In this study, we explored the lncRNA expression profiles in a rat model of MI/R injury and found that the novel lncRNA, lncAABR07025387.1, was highly expressed in MI/R-injured myocardial tissues and hypoxia/reoxygenation (H/R)-challenged myocardial cells. Silencing lncAABR07025387.1 improved MI/R injury in vivo and inhibited myocardial cell ferroptosis under H/R conditions. Bioinformatics analyses and luciferase, pull-down, and RNA-binding immunoprecipitation assays further revealed that lncAABR07025387.1 interacted with miR-205, which directly targeted ACSL4, a known contributor to ferroptosis. Furthermore, downregulating miR-205 reversed the ACSL4 inhibition induced by silencing lncAABR07025387.1. These findings suggest that, mechanistically, lncAABR07025387.1 negatively regulates miR-205 expression and subsequently upregulates ACSL4-mediated ferroptosis. In conclusion, this study demonstrates that lncAABR07025387.1 acts as a competing endogenous RNA during MI/R injury and highlights the therapeutic potential of lncRNAs for treating myocardial injury.https://www.frontiersin.org/articles/10.3389/fcell.2022.672391/fullmyocardial I/R injuryferroptosismiR-205ACSL4lncAABR07025387.1
spellingShingle Weixin Sun
Weixin Sun
Weixin Sun
Weixin Sun
Xiang Wu
Xiang Wu
Xiang Wu
Peng Yu
Peng Yu
Qian Zhang
Qian Zhang
Le Shen
Le Shen
Jiandong Chen
Jiandong Chen
Huaqin Tong
Huaqin Tong
Huaqin Tong
Manlu Fan
Manlu Fan
Manlu Fan
Haibo Shi
Haibo Shi
Haibo Shi
Xiaohu Chen
Xiaohu Chen
LncAABR07025387.1 Enhances Myocardial Ischemia/Reperfusion Injury Via miR-205/ACSL4-Mediated Ferroptosis
Frontiers in Cell and Developmental Biology
myocardial I/R injury
ferroptosis
miR-205
ACSL4
lncAABR07025387.1
title LncAABR07025387.1 Enhances Myocardial Ischemia/Reperfusion Injury Via miR-205/ACSL4-Mediated Ferroptosis
title_full LncAABR07025387.1 Enhances Myocardial Ischemia/Reperfusion Injury Via miR-205/ACSL4-Mediated Ferroptosis
title_fullStr LncAABR07025387.1 Enhances Myocardial Ischemia/Reperfusion Injury Via miR-205/ACSL4-Mediated Ferroptosis
title_full_unstemmed LncAABR07025387.1 Enhances Myocardial Ischemia/Reperfusion Injury Via miR-205/ACSL4-Mediated Ferroptosis
title_short LncAABR07025387.1 Enhances Myocardial Ischemia/Reperfusion Injury Via miR-205/ACSL4-Mediated Ferroptosis
title_sort lncaabr07025387 1 enhances myocardial ischemia reperfusion injury via mir 205 acsl4 mediated ferroptosis
topic myocardial I/R injury
ferroptosis
miR-205
ACSL4
lncAABR07025387.1
url https://www.frontiersin.org/articles/10.3389/fcell.2022.672391/full
work_keys_str_mv AT weixinsun lncaabr070253871enhancesmyocardialischemiareperfusioninjuryviamir205acsl4mediatedferroptosis
AT weixinsun lncaabr070253871enhancesmyocardialischemiareperfusioninjuryviamir205acsl4mediatedferroptosis
AT weixinsun lncaabr070253871enhancesmyocardialischemiareperfusioninjuryviamir205acsl4mediatedferroptosis
AT weixinsun lncaabr070253871enhancesmyocardialischemiareperfusioninjuryviamir205acsl4mediatedferroptosis
AT xiangwu lncaabr070253871enhancesmyocardialischemiareperfusioninjuryviamir205acsl4mediatedferroptosis
AT xiangwu lncaabr070253871enhancesmyocardialischemiareperfusioninjuryviamir205acsl4mediatedferroptosis
AT xiangwu lncaabr070253871enhancesmyocardialischemiareperfusioninjuryviamir205acsl4mediatedferroptosis
AT pengyu lncaabr070253871enhancesmyocardialischemiareperfusioninjuryviamir205acsl4mediatedferroptosis
AT pengyu lncaabr070253871enhancesmyocardialischemiareperfusioninjuryviamir205acsl4mediatedferroptosis
AT qianzhang lncaabr070253871enhancesmyocardialischemiareperfusioninjuryviamir205acsl4mediatedferroptosis
AT qianzhang lncaabr070253871enhancesmyocardialischemiareperfusioninjuryviamir205acsl4mediatedferroptosis
AT leshen lncaabr070253871enhancesmyocardialischemiareperfusioninjuryviamir205acsl4mediatedferroptosis
AT leshen lncaabr070253871enhancesmyocardialischemiareperfusioninjuryviamir205acsl4mediatedferroptosis
AT jiandongchen lncaabr070253871enhancesmyocardialischemiareperfusioninjuryviamir205acsl4mediatedferroptosis
AT jiandongchen lncaabr070253871enhancesmyocardialischemiareperfusioninjuryviamir205acsl4mediatedferroptosis
AT huaqintong lncaabr070253871enhancesmyocardialischemiareperfusioninjuryviamir205acsl4mediatedferroptosis
AT huaqintong lncaabr070253871enhancesmyocardialischemiareperfusioninjuryviamir205acsl4mediatedferroptosis
AT huaqintong lncaabr070253871enhancesmyocardialischemiareperfusioninjuryviamir205acsl4mediatedferroptosis
AT manlufan lncaabr070253871enhancesmyocardialischemiareperfusioninjuryviamir205acsl4mediatedferroptosis
AT manlufan lncaabr070253871enhancesmyocardialischemiareperfusioninjuryviamir205acsl4mediatedferroptosis
AT manlufan lncaabr070253871enhancesmyocardialischemiareperfusioninjuryviamir205acsl4mediatedferroptosis
AT haiboshi lncaabr070253871enhancesmyocardialischemiareperfusioninjuryviamir205acsl4mediatedferroptosis
AT haiboshi lncaabr070253871enhancesmyocardialischemiareperfusioninjuryviamir205acsl4mediatedferroptosis
AT haiboshi lncaabr070253871enhancesmyocardialischemiareperfusioninjuryviamir205acsl4mediatedferroptosis
AT xiaohuchen lncaabr070253871enhancesmyocardialischemiareperfusioninjuryviamir205acsl4mediatedferroptosis
AT xiaohuchen lncaabr070253871enhancesmyocardialischemiareperfusioninjuryviamir205acsl4mediatedferroptosis